EE62 COST-EFFECTIVENESS ANALYSIS OF TISOTUMAB VEDOTIN VS. CHEMOTHERAPY IN PATIENTS WITH RECURRENT OR METASTATIC CERVICAL CANCER

IF 1.9 Q3 HEALTH CARE SCIENCES & SERVICES

Value in health regional issues Pub Date : 2026-10-01 Epub Date: 2026-10-17 DOI:10.1016/j.vhri.2026.101779

Yuka Matsui MS, Yoshinori Maki MS, Kensuke Moriwaki BS, MS, PhD

引用次数: 0

查看原文本刊更多论文

复发或转移性宫颈癌患者使用噻妥单抗与化疗的成本-效果分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Value in health regional issues Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

CiteScore

2.60

自引率

5.00%

发文量

127